Association of Smoking with Increasing Vascular Involvement in Type 2 Diabetic Chinese Patients

Abstract

Purpose: To identify the relationship between smoking and the metabolic profile and existing vascular disease in Chinese type 2 diabetic patients. Methods: 1710 diabetic patients were screened for complications, and biochemical and anthropometric vascular risk factors. As most smokers were male, differences were only compared between male current (n = 196) and never smoking patients (n = 300). Results: The smokers had higher glycosylated haemoglobin levels (8.2 ± 2.0 vs. 7.6 ± 1.8 %, p < 0.001) than never smokers, despite a greater proportion receiving hypoglycaemic agents (87.5 vs. 79.6 %, p = 0.003). Male smokers compared to never smokers had lower HDL-cholesterol levels (1.12 ± 0.31 vs. 1.20 ± 0.30 mmol/L, p = 0.006), and elevated albumin-to-creatinine ratio (3.57 [2.68 - 4.75] vs. 2.47 [1.99 - 3.05] mg/mmol, p = 0.040). However, diastolic blood pressure was lower in the smoking group (78 ± 12 vs. 82 ± 12 mmHg, p = 0.001) even though they received less blood pressure-lowering treatments (23.8 vs. 33.2 %, p = 0.034). The prevalence of peripheral vascular disease was increased in the diabetic patients who smoked compared to nonsmokers (7.1 vs. 2.8 %, p = 0.039). Conclusions: Smoking was associated with a more adverse metabolic profile and peripheral vascular disease. As mainland China undergoes rapid modernisation and urbanisation, the observed effects of smoking means tobacco control becomes increasingly important to prevent or minimise potential health impacts and chronic disease.

Key words

Cardiovascular disease - metabolic syndrome - middle cerebral artery stenosis - smoking - peripheral vascular disease - retinopathy

References

• 1 Surgeon General .The Health Benefits of Smoking Cessation: A Report of the Surgeon General, 1990. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Public. No. (CDC) 90 - 8416. Rockville, MD, USA; 1990
• 2 Berglund G, Wilhelmsen L. Factors related to blood pressure in a general population sample of Swedish men.  Acta Med Scand. 1975;  198 291-298
• 3 Cheung C K, Swaminathan R. Rapid, economical immunoturbidimetric method for albuminuria.  Clin Chem. 1987;  33 204-205
• 4 Davis J W, Shelton L, Eigenberg D A, Hignite C E, Watanabe I S. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets.  Clin Pharmacol Ther. 1985;  37 529-533
• 5 Janus E D Hong Kong Cardiovascular Risk Factor Prevalence Study Group for the . the Hong Kong Cardiovascular Risk Factor Prevalence Study 1995 - 1996. Hong Kong; 1997
• 6 Fowkes F GR, Housley E, Riemersma R A, MacIntyre C CA, Cawood E HH, Prescott R J, Ruckley C V. Smoking, lipids, glucose intolerance and blood pressure as risk factors for peripheral atherosclerosis compared to ischaemic heart disease: Edinburgh Artery Study.  Am J Epidemiol. 1992;  135 331-340
• 7 Haffner S M, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.  N Engl J Med. 1998;  339 229-234
• 8 Howard G, Wagenknecht L E, Burke G L, Diez-Roux A, Evans G W, McGovern P, Nieto F J, Tell G S. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study.  JAMA. 1998;  279 119-124
• 9 Jones R B, Hedley A J. Prevalence of smoking in a diabetic population: the need for action.  Diabet Med. 1987;  4 233-236
• 10 Lam T H, He Y, Li L S, He S F, Liang B Q. Mortality attributable to cigarette smoking in China.  JAMA. 1997;  278 1505-1508
• 11 Lam T H, Ho S Y, Hedley A J, Mak K H, Peto R. Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998.  Br Med J. 2001;  323 361-367
• 12 Lam T H, Jiang C Q, Ho S Y, Zhang W S, Liu W W, He J M. Smoking and mortality in 81 344 drivers in Guangzhou, China.  Occup Environ Med. 2002;  59 135-138
• 13 Leng G C, Lee A J, Fowkes F G, Whiteman M, Dunbar J, Housley E, Ruckley C V. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.  Int J Epidemiol. 1996;  25 1172-1181
• 14 Lerman A, Holmes Jr D R, Bell M R, Garratt K N, Nishimura R A, Burnett Jr J C. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.  Circulation. 1995;  92 2426-2431
• 15 Libby P. Current concepts of the pathogenesis of the acute coronary syndromes.  Circulation. 2001;  104 365-372
• 16 Mogensen C E, Vestbo E, Poulsen P L, Christiansen C, Damsgaard E M, Eiskjær H, Frøland A, Hansen K W, Nielsen S, Pedersen M M. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.  Diabetes Care. 1995;  18 572-581
• 17 Narkiewicz K, van de Borne P J, Hausberg M, Cooley R L, Winniford M D, Davison D E, Somers V K. Cigarette smoking increases sympathetic outflow in humans.  Circulation. 1998;  98 528-534
• 18 Orth S R, Ritz E. The renal risks of smoking: an update.  Curr Opin Nephrol Hypertens. 2002;  11 483-488
• 19 Poulter N R. Independent effects of smoking on risk of hypertension: small, if present.  J Hypertens. 2002;  20 171-172
• 20 Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishnr M. Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.  Ann Intern Med. 1993;  118 577-581
• 21 Sacco R L. Risk factors, outcomes, and stroke subtypes for ischemic stroke.  Neurology. 1997;  49 S39-S44
• 22 Taylor A E, Johnson D C, Kazemi H. Environmental tobacco smoke and cardiovascular disease: a position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association.  Circulation. 1992;  86 699-702
• 23 Thomas G N, Critchley J AJH, Tomlinson B, Cockram C S, Chan J CN. Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors.  Diabet Med. 2003 a;  20 988-995
• 24 Thomas G N, Critchley J AJH, Tomlinson B, Lee Z SK, Young R P, Chan J CN. Albuminuria and the renin-angiotensin system gene polymorphisms in type 2 diabetic and in normoglycaemic hypertensive Chinese.  Clin Nephrol. 2001 a;  55 7-15
• 25 Thomas G N, Lin J W, Lam W W, Tomlinson B, Yeung V, Chan J C, Liu R, Wong K S. Increasing severity of cardiovascular risk factors with increasing middle cerebral artery stenotic involvement in type 2 diabetic Chinese patients with asymptomatic cerebrovascular disease.  Diabetes Care. 2004;  27 1121-1126
• 26 Thomas G N, Lin J W, Lam W WM, Tomlinson B, Yeung V TF, Chan J CN, Wong K S. Middle cerebral artery stenosis in type 2 diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the renin-angiotensin system genes.  Cerebrovascular Diseases. 2003 b;  16 217-223
• 27 Thomas G N, Tomlinson B, Chan J CN, Sanderson J E, Cockram C S, Critchley J AJH. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia and diabetes in Hong Kong Chinese: a significant association of the ACE insertion/deletion polymorphism with type 2 diabetes.  Diabetes Care. 2001 b;  24 356-361
• 28 Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A M, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.  Circulation. 1994;  90 583-612
• 29 Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function.  Med Sci Monit. 2001;  7 1075-1085
• 30 Vlassara H, Palace M R. Diabetes and advanced glycation endproducts.  J Intern Med. 2002;  251 87-101
• 31 Woo K S, Chook P, Leong H C, Huang X S, Celermajer D S. The impact of heavy passive smoking on arterial endothelial function in modernized Chinese.  J Am Coll Cardiol. 2000;  36 1228-1232
• 32 Woo K S, Chook P, Lolin Y I, Cheung A SP, Chan L T, Sun Y Y, Sanderson J E, Metreweli C, Celemajer D S. Hyperhomocysteinaemia is a risk factor for arterial endothelial dysfunction in humans.  Circulation. 1997 a;  96 2542-2544
• 33 Woo K S, Chook P, Raitakari O T, McQuillan B, Feng J Z, Celermajer D S. Westernization of Chinese adults and increased subclinical atherosclerosis.  Arterioscler Thromb Vasc Biol. 1999;  19 2487-2493
• 34 Woo K S, Robinson J TC, Chook P, Adams M R, Yip G, Mai Z J, Lam C WK, Sorensen K E, Deanfield J E, Celermajer D S. Differences in the effect of cigarette smoking on endothelial function in Chinese and Caucasian adults.  Ann Intern Med. 1997 b;  127 372-375
• 35 World Health Organization .world health statistics annual 1994. Geneva; WHO 1995
• 36 World Health Organization report of the expert committee on the diagnosis and classification of diabetes mellitus.  Diabetes Care. 1997;  20 1183-1197
• 37 Young R P, Thomas G N, Critchley J AJH, Tomlinson B, Woo K S, Sanderson J E. Interethnic differences in coronary heart disease mortality in 25 populations: association with the angiotensin-converting enzyme DD genotype frequency.  J Cardiovasc Risk. 1998;  5 303-307